Newsfiscal.ai
Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra for Knee Osteoarthritis
· Published
Article summary
Enlivex has reached a significant milestone in its Phase 2b clinical trial, with 135 of the planned 182 patients randomized and receiving their first injection of Allocetra.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…